JAGXJaguar Health, Inc.

Nasdaq jaguar.health


$ 0.17 $ -0.09 (-34.78 %)    

Monday, 20-May-2024 15:59:49 EDT
QQQ $ 454.82 $ -0.45 (-0.1 %)
DIA $ 398.57 $ -0.18 (-0.05 %)
SPY $ 530.36 $ 0.21 (0.04 %)
TLT $ 91.26 $ -0.04 (-0.05 %)
GLD $ 225.37 $ -0.10 (-0.04 %)
$ 0.1686
$ 0.16
$ 0.00 x 0
$ 0.00 x 0
$ 0.14 - $ 0.17
$ 0.05 - $ 0.75
64,940,322
na
26.78M
$ 1.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-22-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-17-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 04-03-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-21-2019 03-31-2019 10-Q
22 04-10-2019 12-31-2018 10-K
23 11-19-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-09-2018 12-31-2017 10-K
27 11-20-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 02-15-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-29-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 06-26-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-jaguar-health-stock-is-tanking

Jaguar Health shares are falling Monday after the company announced a 1-for-60 reverse stock split. The company will effect a r...

 jaguar-health-announces-submission-of-clinical-trial-applications-for-crofelemer-to-treat-rare-disease-indications-microvillus-inclusion-disease-and-short-bowel-syndrome-in-europe

Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the Europea...

 fda-conditionally-approves-jaguar-healths-prescription-drug-crofelemer-for-chemotherapy-induced-diarrhea-in-dogs

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the v...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION